BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32300923)

  • 21. MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice.
    De Vos L; Declercq J; Rosas GG; Van Damme B; Roebroek A; Vermorken F; Ceuppens J; van de Ven W; Creemers J
    Int J Oncol; 2008 May; 32(5):1073-83. PubMed ID: 18425334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pathology of salivary glands. Tumors of the salivary glands].
    Mahy P; Reychler H
    Rev Belge Med Dent (1984); 2006; 61(3):141-53. PubMed ID: 17408135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli.
    Leonardi A; Tarricone E; Corrao S; Alaibac M; Corso AJ; Zavan B; Venier P; Conway de Macario E; Macario AJ; Di Stefano A; Cappello F; Brun P
    Allergy; 2016 Mar; 71(3):403-11. PubMed ID: 26613380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary gland tumors in atomic bomb survivors, hiroshima, japan. II. Pathologic study and supplementary epidemiologic observations.
    Takeichi N; Hirose F; Yamamoto H; Ezaki H; Fujikura T
    Cancer; 1983 Jul; 52(2):377-85. PubMed ID: 6305475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Pathology and Biomarkers.
    Ha PK; Stenman G
    Adv Otorhinolaryngol; 2016; 78():17-24. PubMed ID: 27092959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary gland tumors: review of 643 cases.
    Main JH; Orr JA; McGurk FM; McComb RJ; Mock D
    J Oral Pathol; 1976 Mar; 5(2):88-102. PubMed ID: 176335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective review of 139 major and minor salivary gland tumors.
    Trenkić Božinović M; Krasić D; Katić V; Krstić M
    Med Glas (Zenica); 2015 Feb; 12(1):73-8. PubMed ID: 25669341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of hepatocyte growth factor expression with salivary gland tumor differentiation.
    Tsukinoki K; Yasuda M; Asano S; Karakida K; Ota Y; Osamura RY; Watanabe Y
    Pathol Int; 2003 Dec; 53(12):815-22. PubMed ID: 14629746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathology of head and neck tumors: salivary glands, part 1.
    Batsakis JG; Regezi JA
    Head Neck Surg; 1978; 1(1):59-68. PubMed ID: 756396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumors of salivary glands. Review of 479 cases with particular reference to histological types, site, age and sex distribution.
    Martin VT; Salmaso R; Onnis GL
    Appl Pathol; 1989; 7(3):154-60. PubMed ID: 2669862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for correlation of radon levels and incidence of salivary gland tumors.
    Miller AS; Harwick RD; Alfaro-Miranda M; Sundararajan M
    Oral Surg Oral Med Oral Pathol; 1993 Jan; 75(1):58-63. PubMed ID: 8419877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant salivary gland tumours in Sweden 1960-1989--an epidemiological study.
    Ostman J; Anneroth G; Gustafsson H; Tavelin B
    Oral Oncol; 1997 May; 33(3):169-76. PubMed ID: 9307725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of vitamin B12 R-binder in salivary gland tumors. Implications for cell differentiation.
    Ogawa K; Ogawa O; Koshiba M; Sugiyama T; Wakatsuki Y; Kudo H; Kim YC; Nakashima Y; Yamabe H
    Pathol Res Pract; 1990 Dec; 186(6):751-8. PubMed ID: 2084638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management.
    Badlani J; Gupta R; Balasubramanian D; Smith J; Luk P; Clark J
    ANZ J Surg; 2018 Mar; 88(3):152-157. PubMed ID: 28982213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of selected glycosidases in salivary gland tumors.
    Bierc M; Minarowski L; Woźniak L; Chojnowska S; Knas M; Szajda S; Zwierz K
    Folia Histochem Cytobiol; 2010 Sep; 48(3):471-4. PubMed ID: 21071355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of salivary gland tumors in a Nigerian tertiary institution.
    Fomete B; Adebayo ET; Ononiwu CN
    Ann Afr Med; 2015; 14(3):148-54. PubMed ID: 26021396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
    Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms.
    Xu XC; Sola Gallego JJ; Lotan R; El-Naggar AK
    Int J Oncol; 2000 Aug; 17(2):271-6. PubMed ID: 10891535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological correlations of insulin resistance and salivary gland tumors].
    Suba Z; Barabás J; Takács D; Szabó G; Ujpál M
    Orv Hetil; 2005 Aug; 146(33):1727-32. PubMed ID: 16206887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoexpression of growth factors and receptors in polymorphous low-grade adenocarcinoma.
    Rosa AC; Soares AB; Santos FP; Furuse C; de Araújo VC
    J Oral Pathol Med; 2016 Aug; 45(7):494-9. PubMed ID: 26671844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.